NetworkNewsWire Newsroom

Monday, May 3, 2021

DGE’s 4th Virtual Clinical Trials Conference

Monday, May 17, 2021

On Monday, May 17th, 2021, pharma companies, medical vendors, and clinicians are invited to attend the 4th Virtual Clinical Trials conference – the industry’s leading, longest-lasting conference on virtual clinical trials. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

On May 17-18th The 4th Virtual Clinical Trials will increase your ability to execute your decentralized trial, reduce site visits, accelerate timelines and gather data faster. Hear from top industry experts that will give you the tools to implement remote trials and reduce workloads for clinical trial sites at an accelerated rate.

The 2-day event will feature speeches, keynotes, and discussions from over 25 speakers on the increasing needs, benefits, and potential of virtual clinical trials. The 4th Virtual Clinical Trials Conference offers this unique opportunity to sponsors, and pharma companies to understand the potential of virtual clinical trials and how to remove roadblocks and barriers for collecting and utilizing patient data.

The event will commence with an introductory speech by Craig Lipset, founder of Clinical Innovation Partners. Craig Lipset is a visionary leading the forefront of innovations in clinical research and medicine development.

Influential Opinion Leaders who will present will include:

Angel Soubhie, BAYER, HEAD CLINICAL TRIAL SCIENTISTS – MEDICAL DIRECTOR
Jeremy Price, PFIZER, DIRECTOR, CLINICAL OPERATIONS STRATEGIC PARTNERSHIPS
Antonieta Sosa, JANSEEN, DIRECTOR, CLINICAL INNOVATION
Stephen Lutsch, LEO PHARMA, DIRECTOR, HEAD OF REVOLUTIONIZE CLINICAL TRIALS
Maimah Karmo, TIGERLILY FOUNDATION, CEO, PATIENT ADVOCATE

Clinicians, trial managers, clinical data experts, vendors, pharma companies, and scientists should leverage the opportunity offered by the event, as it is will showcase:

A roadmap for turning urgent responses to COVID into permanent new processes that will keep your momentum going
Best practice on updating SOPs for these unprecedented problems
Strategies to maintain patient centricity, safety, and feedback throughout the trial
An up-to-date review of new assessments and expectations from regulators
Key techniques for collaborating around new data standards with service providers

COVID-19 has increased the need for virtual clinical trials. The key theme and the objective of the conference is to discuss and discover the innovation, recruitment, and application of virtual clinical trials to a wider pharma sector while keeping the patient experience in mind.

For tickets to the event, please visit https://nnw.fm/RZ1QN

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

InvestorBrandNetwork Executive Discusses Company’s Path to IR Success

InvestorBrandNetwork (“IBN”) is a multi-faceted communications organization that connects publicly traded companies to the investment community
IBN founder and Managing Director Michael McCarthy recently appeared in a Stock2Me podcast to discuss the company’s strategies for building clientele and keeping their business while providing investors with a wide variety of options to consider
The ongoing COVID-19 pandemic has driven a number of changes in how target audiences are gaining information, which has led to new approaches to disseminating information at IBN during the past year
The company’s addition of podcasts and ITT solutions to its array of IR, PR, social media and articles help clients reach investors as media channels continue to evolve

A multi-faceted communications organization that connects publicly traded companies to the investment community through a vast network of content creation and distribution measures presented an insider’s look at the strategies that have guided its success during a recent addition to its Stock2Me podcast series (https://nnw.fm/OdnKq).

InvestorBrandNetwork (“IBN”) has worked with more than 500 public and pre-IPO companies over the course of its 15-plus-year history, amassing a collective audience that includes millions of followers and subscribers through varied media channels. IBN’s most recent Stock2Me podcast highlights a fireside chat founder and Managing Director Michael McCarthy conducted during Investor Summit Group’s March 23-25 Q1 event, where attendees had the opportunity to discuss topics in the investment space with high-quality, vetted investors and handpicked executives.

McCarthy said his driving philosophy as an investment relations professional and marketing business executive largely arises from his military father’s emphasis on “plan, plan, plan and plan some more.”

“Most clients, they come to us and (they’ll say), ‘My stock is undervalued,’ ‘I don’t trade enough,’ ‘My stock price is depressed,’ ‘I should be raising money,’ ‘My technical analysis people say I should be here,’ And all that is really happy horsesh_,” McCarthy noted. “You’ve got to have a plan, and then all the other things are going to get fixed … no matter what. … But if you don’t have a plan in the beginning of the relationship with us or whoever you use, it’s absolutely not going to work.”

McCarthy discussed how investors get their trading and investment ideas in the modern era, the importance of coordinating a successful digital communications plan with a wide array of clientele, ways IBN maintains long-term client commitment and increases its social media following, and the value of strategically placing content in the official newsfeeds of other companies.

Two key components of IBN’s strategy in the current market climate involve truth in advertising and adapting to the audience’s circumstances to find people where they are.

“We invested six digits on … podcasting development, and then where we’re also focused is the over-the-top platform,” McCarthy said. “OTT, or over-the-top platforms, really were not in existence prior to the pandemic. But what ended up happening is, again, the pandemic hit and (people were) like, ‘Hey, now I can see this content online.’ … Things I never would have thought of before the pandemic we now do.”

In terms of transparency, IBN undergirds its varied IR, PR, social media and articles solutions with a focus on reporting monthly to the clients on what the company has done and determining what the client wants or does not want.

“Most of our competitors now, nobody was doing any reporting,” McCarthy said. “We give all of our clients monthly reports. Every single month, everything that we’ve done, all the good and all the bad. … So that’s why our clients love us. … As clients start to see that, they’re not looking around, they’re not looking for the door.”

In turn, as investors see the number of clients IBN represents at any given time, they can weigh options in a variety of markets, whether large public companies or private companies raising money through a Reg-A offering.

“We have so much variety. So when you come shopping at IBN, and you’re looking for an investment, we’re not like most IR companies that have three, five, 12 companies, that’s it — we have 80,” he said. “And we’re not a promotional house going, ‘Hey, buy this stock, it’s going to the moon!’ We’re more about research and development. … We’re there when the stock’s up, we’re there when the stock’s down, we’re there ongoing so (clients) always know that they have a support mechanism at IBN to help them move forward.”

For more information about InvestorBrandNetwork and its investment marketing solutions, visit the company’s website at https://www.investorbrandnetwork.com.

About NetworkNewsWire

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Sharing Services Global Corp. (SHRG) Poised to Capitalize as Consumers Expected to Binge on “Revenge Travel”

As vaccine rollout continues nationwide, pent-up demand is expected to burst, fueled by massive reserves of excess savings
Economists expect record consumer spending over the next two quarters, at levels not seen in the past 70 years
SHRG seizes lucrative market opportunities, leverages business model to enter the travel sector

Sharing Services Global (OTCQB: SHRG), a publicly traded company specializing in direct selling and other sectors, has once again demonstrated its ability to make quick moves as market forces shift. The company has announced plans to penetrate the travel sector as consumers should be eager to travel again soon. Travel appears on the verge of a boom, and SHRG looks poised to take its share of this growth opportunity.

As more and more people get the COVID-19 vaccine, businesses are trying to determine what consumer spending will look like in the future — and the outlook seems promising. The economy appears on the cusp of a major boom cycle that economists believe could last (https://nnw.fm/KWW5Q).

Since the beginning of the pandemic, Americans have accumulated massive reserves of excess savings, estimated by Bloomberg Economics at a staggering $1.7 trillion in January this year. Although Americans’ worries about health and safety will likely linger, there’s pent-up demand due to this enormous amount of resources.

Consumer spending over the next two quarters is expected to be the strongest in the last 70 years, and leisure expenditures may lead the way. As the economy reopens, consumers are likely to binge on so-called “revenge spending” on the things they were denied over the last year, such as travel, entertainment, and dining (https://nnw.fm/Uvvvs).

The travel sentiment is clearly on the upswing — recent numbers released by the U.S. Travel Association show that in January 2020, 63% of Americans had plans to travel over the next six months, up from 57% in mid-December. After a year of lockdowns due to the pandemic, consumer sentiment is picking up as the rollout of the COVID-19 vaccine gathers steam across the country (https://nnw.fm/6NR1E). Air travel is surging, and hotel bookings appear to be on the path of recovery (https://nnw.fm/DPizm).

Quick to recognize market shifts as they start to emerge, SHRG is entering into the travel industry to capitalize on this swelling opportunity that is likely to endow the previously decimated travel sector. The company plans to leverage its proven business model to provide superior travel products and experiences through broad access to savings and exclusive benefits. The travel company, one of SHRG’s subsidiaries, is intended to be an exclusive travel club offering a “Passport to Happiness” to brand partners and customers.

Confident that now is the most opportune time to make this strategic move, as the next months will likely see people rushing to start traveling again, Sharing Services Global appears poised to capitalize on the major shift in consumer spending.

For more information, visit www.SHRGInc.com and www.TheHappyCo.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://nnw.fm/SHRG

About NetworkNewsWire

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Makes Headway into Canadian Cannabis Vape Market with 25,000 Unit Production Run

Production underway for 25,000 vape cartridges using PULL full spectrum oil formulations, including Super Lemon Haze, Grand Daddy Purple and Girl Scout Cookies/GSK
Company estimates retail sales revenue for this production run will be approximately $750,000
60% of respondents in StatCan’s Canadian 2020 Cannabis Survey that used vaporizer for cannabis in the last 12 months used oil/extracts

“Cannabis 2.0,” the colloquial term for legalization of cannabis derivatives in Canada late in 2019, represented the outset of new trends in how people consume cannabis products with the accessibility of goods like drinks and vape products. While some companies have devoted considerable resources to in-house extraction technologies, the market is still relatively scant for certified extractors that can meet demand for concentrates from cannabis biomass. This is the focus of Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), which just experienced a milestone moment with commencement of production of 25,000 vape cartridges for the Canadian retail market.

The Company operates a 10,000 sq. ft., Health Canada licensed facility in Pemberton, British Columbia, constructed to EU-GMP standards, aligning Pure Extracts for international distribution. The bespoke facility houses equipment for cutting-edge CO2 and ethanol extraction capabilities and processes, with phase 2 plans to build-out underutilized space into an R&D and production center for functional and psychedelic mushrooms. The Company intends to become a go-to company in extraction for multiple markets, with capacity to process both cannabis and hemp biomass as well as functional and psychedelic mushrooms in order to satisfy clients’ needs.

In Statistic Canada’s Canadian 2020 Cannabis Survey that included nearly 11,000 respondents, a new question was posed. Of the people that used a vaporizer to ingest cannabis in the last 12 months, 60% said they used cannabis oil/extract (https://nnw.fm/zPZgJ).

Demand for Pure Extracts’ Pure Pulls branded 510 Vape cartridges is strong in the provincial markets in Canada. 510 cartridges are the most popular on the market today and so named to describe the threading that attaches the cartridge to the vape battery. The Company has teamed up with a leading global manufacturer of premium cartridges that dovetails with Pure Extracts’ expectations for the highest quality components and performance when paired with its oil concentrates.

The production plans call for the cartridges to be filled with selections from the Company’s proprietary library of more than 30 full spectrum oil (“FSO”) formulations, including Super Lemon Haze, Grand Daddy Purple and Girl Scout Cookies/GSK. Management estimates retail sales from the production run to be approximately $750,000.

“We are excited about preparing to ship our first vape cart orders to the provincial distribution channels,” said Pure Extracts CEO Ben Nikolaevsky in a recent press release (https://nnw.fm/fSwpn). “We have created the high quality FSO vape products that consumers now demand and believe that we will quickly build brand loyalty with both legacy and new entrants in the vape space.”

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at https://nnw.fm/PULL

About NetworkNewsWire

NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork

Healthtech Solutions Inc. (HLTT) Adopts New Portfolio Model with Varian Bio Acquisition

McKinsey & Company notes that portfolio model is growing in popularity amongst companies and investors
HLTT recently acquired precision oncology company Varian Biopharma
Report shows that more than $5.5 billion in capital has been raised in past six years by companies with biotech portfolio models

An emerging trend in biotechnology involves abandoning a single shot on goal approach in favor of a broader strategy with different portfolio companies under one umbrella. The old incubator approach with a new flare, the trend involves a portfolio manager utilizing a variety of skillsets to assemble a group of subsidiaries, each committed to a different specialty or drug program. It can be a de-risking methodology that simultaneously amplifies the upside of the parent company, and biotech players like Healthtech Solutions (OTC: HLTT) have pivoted to this model, primarily through its recent acquisition of Varian Biopharmaceuticals (https://nnw.fm/BShIh).

With the buyout of Varian Biopharma, Healthtech expanded its portfolio to three distinct healthcare subsidiaries. MediScan, Inc. has developed disruptive technology that converts 2D images from a portable ultrasound machine into 3D, high-definition images, a leap forward in imaging to improve diagnoses by providing point-of-care imaging on par with X-rays, MRIs and CT scans. The company’s RevHeart unit is advancing critical research into the treatment of COVID-related heart muscle injury.

As noted in a recent report by McKinsey & Company, the model is growing in popularity amongst companies and investors. Firms like BridgeBio Pharma (NASDAQ: BBIO) and Biohaven Pharmaceutical (NYSE: BHVN) are two blue chips operating under the central-management-with-multiple-subsidiaries structure, demonstrating the strong investor interest. All told, the report shows that more than $5.5 billion in capital has been raised in the past six years by companies with biotech portfolio models (https://nnw.fm/Acs08).

Varian Biopharma, which will be housed as a new Healthtech Oncology, Inc. subsidiary, is a precision oncology company specializing in the development of atypical protein kinase C iota, or aPKCi, inhibitors for different tumor types. Varian Bio’s two lead candidates are still being prepared for clinical trials. VAR-101 is a topical formulation for basal cell carcinoma, the most common type of skin cancer, affecting about 4.3 million Americans each year (https://nnw.fm/zVFqG). VAR-102 is an experimental oral drug that will be tested against a battery of resilient tumors where research has shown aPCKi inhibition could be an effective pathway, including pancreatic, colorectal and non-small cell lung cancers (“NSCLC”).

A new approach in precision oncology, aPKCi inhibition innovates through regulation of transcription factors such as GLI-1 and K-RAS—proteins known to be integral in cancer pathogenesis. Varian appears to be on the leading edge, as K-RAS G12C is considered the most prevalent emerging biomarker in NSCLC (https://nnw.fm/9IPEF).

Investors from small retail to institutions seem to value the new model over the traditional straight-line approach of biotech. The rewards could be great in the traditional model, but with the odds weighing in only around 5% at best that any pre-clinical biotech asset would make it to launch, the risks are equally high.

The acquisition of Varian by Healthtech plays to the strengths of the new portfolio model not only in drug pipeline but also by bringing in experts in an area that could attract additional investment. Again, that’s an appetizing part of the basket model. “The fact that [Varian Bio is] developing therapies to target difficult-to-treat cancers such as pancreatic cancer demonstrates just how innovative their team is,” said Healthtech Solutions Chairman and CEO David Rubin in a statement disclosing the acquisition. “Precision oncology is an exciting field and we’re thrilled to be a part of it,” he added.

For more information, visit the company’s website at www.MyMediScan.com.

NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://nnw.fm/HLTT

About NetworkNewsWire

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

SRAX Inc. (NASDAQ: SRAX) Hosts First-Ever Sequire Cannabis Conference Featuring 40 Company Presentations, Exclusive Keynote Interviews

SRAX held first-ever virtual Sequire Cannabis Conference on April 20, 2021
Event featured over 40 cannabis company presentations, keynote appearances by Steve DeAngelo, Dr. Sue Sisley, Emily Paxhia, Steven Hawkins, Dr. Jeffrey Chen
Sequire provides data analytics tools that help public companies track investor activity, such as investor tracking, warrant management, shareholder surveys
Sequire has grown to over 3 million users across 183 companies since 2019

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, recently held its first-ever virtual Sequire Cannabis Conference on April 20, 2021 (https://nnw.fm/nL7pn). Nearly one million active small-cap investors were invited to the event, which featured presentations by over 40 cannabis companies along with keynote appearances by prominent industry experts such as Steve DeAngelo, Dr. Sue Sisley, Emily Paxhia, Steven Hawkins, and Dr. Jeffrey Chen.

The cannabis industry has undergone seismic shifts in the last decade that included the publication of notable scientific studies and extensive research reviews (https://nnw.fm/tDAfE), along with legalization in several states (https://nnw.fm/oihqd). The industry has since exploded with thousands of new companies in various sectors, including plant genetics cultivation, product development, e-commerce portals and physical dispensaries across the United States.

Presenting at the Cannabis Conference were prominent industry leaders such as Steve DeAngelo, a lifelong activist, entrepreneur and co-founder of Harborside, The Arcview Group, The Last Prisoner Project non-profit organization, and the Radio Free Cannabis podcast. He was interviewed by Emily Paxhia, an investment expert who has reviewed thousands of companies in the cannabis space in addition to working with numerous founders in various capacities.

Also featured at the conference were interviews with Dr. Sue Sisley and Steve Hawkinsby Dr. Jeff Chen, co-founder and CEO of Radicle Science, and Founder and Director of the UCLA Cannabis Research Initiative. Sisley is an Arizona-based physician, President of Scottsdale Research, and Principal Investigator for FDA-approved randomized controlled trials. Hawkins is the President & CEO of the United States Cannabis Council and Executive Director of the Marijuana Policy Project.

The Cannabis Conference is one of many industry-specific events SRAX plans to host on Sequire this year. Besides event management, the platform empowers public companies with data analytics tools that include investor tracking, warrant management, and shareholder surveys. Since its 2019 inception, the platform has grown to include over 3 million users across 183 public companies and is rapidly becoming the premier analytics platform in the investment space (https://nnw.fm/EcwO2).

SRAX is a financial technology company that unlocks data and insights for publicly traded companies. Through its investor intelligence and communications platform, Sequire, companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels.

Replays of SRAX’s Sequire Cannabis Conference can be accessed at https://cannabis-conference.mysequire.com/.

For more information, visit the company’s websites at www.SRAX.com and www.MySequire.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://nnw.fm/SRAX

About NetworkNewsWire

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.

Infobird Co., Ltd (NASDAQ: IFBD) Taking Next Step in AI-driven Customer Engagement Field with IPO

Beijing-based Infobird has built rich experience in the customer engagement industry that covers SaaS solutions such as cloud call center, intelligent telemarketing, AI Chatbots, and has now closed its IPO on the NASDAQ exchange.
Infobird’s artificial intelligence (“AI”) solutions help clients to minimize costs and maximize potential revenues.
The company’s self-developed cloud-native architecture and patented AI technologies work with a no-code development platform to help companies focus their efforts and financial outlays where they are most needed.

B2B artificial intelligence (“AI”) solutions company Infobird (NASDAQ: IFBD) is building next-level operations in tandem with the Beijing, China-based company’s April 20 IPO debut on The Nasdaq Capital Market (https://nnw.fm/umWhv).

Infobird has built a reputation as a premier provider of customer engagement SaaS solutions in China that use automated and smart solutions to maximize value for its clients through reduced corporate costs that don’t impinge on the clients’ ability to generate and increase revenues.

The company’s self-developed cloud cloud-native architecture and patented AI technologies, for example, work with a no-code development platform that allows enterprise-building companies to focus on managing their operations as they know best, while relying on the technological expertise of application builders for only the most necessary development efforts, likewise enabling the automation of AI-empowered call center features to handle many of the routine and repetitive functions that human personnel might otherwise be needed for in large numbers.

Infobird is one of the first enterprises to apply intelligent technology to customer service industry. Over the past decade, the company has built a client base of over 10,000 paid user accounts from 358 customers in finance, education, public services, consumer products and health care. While its primary focus is on key corporations in the finance industry, it has served clients from other industries as well, such as e-commerce giant Alibaba (NYSE: BABA).

As one of the leading software-as-a-service (SaaS) providers in China, Infobird uses a highly successful business model in which centrally hosted software is licensed to customers via a subscription plan that not only generates recurring revenue but also opens wide channels of ancillary revenue streams. The SaaS sector has experienced significant growth in recent years and China is now the second-largest market in the world for cloud infrastructure spending.

During the past 20 years, Infobird has continually expanded its technological boundaries, acknowledging that the “intelligence” of intelligent customer service cannot be realized by a single technology and must instead depend on the interaction and integration of various technological systems.

With the explosion of big data, AI and other technologies, Infobird has continuously integrated voice recognition, intelligent interaction and other technologies into its product research and development.

By integrating big data, AI, cloud computing, 5G and other technologies, the company can provide smart and value-added solutions for all customer engagement processes and thus empower the enterprises to better interact with their customers, to reduce costs for the operation and ultimately to increase sales revenue.

For more information, visit the company’s website at www.Infobird.com/en/index.html

NOTE TO INVESTORS: The latest news and updates relating to IFBD are available in the company’s newsroom at https://nnw.fm/IFBD

About NetworkNewsWire

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire is part of the InvestorBrandNetwork.